Tamura T, Mitsumori K, Onodera H, Takahashi M, Funakoshi T, Yasuhara K, Takegawa K, Takagi H, Hirose M
Division of Pathology, National Institute of Health Sciences, Tokyo, Japan.
J Toxicol Sci. 1999 Aug;24(3):145-55. doi: 10.2131/jts.24.3_145.
Time course changes in thyroid proliferative lesions as well as related hormone levels in the blood of male F344 rats given N-bis(2-hydroxypropyl)nitrosamine (DHPN: 2800 mg/kg body weight, single s.c. injection) as an initiation treatment followed by pulverized basal diet containing 0% (Group 2), 2% (Group 3) or 4% (Group 4) kojic acid (KA) were examined at Weeks 1, 2, 4, 8 and 12. As an untreated control group (Group 1), rats were given basal diet for 13 weeks and examined in the same manner. Serum T3/T4 levels in the DHPN + 2% KA and DHPN + 4% KA groups were significantly reduced as compared with the DHPN-alone group at each time point. Serum TSH levels in both DHPN + KA groups were significantly increased at each time point in a treatment period-dependent manner from Weeks 1 to 12, and the extent of elevation was more remarkable in the DHPN + 4% KA group. At Week 2, there were no statistically significant intergroup differences in liver T4-UDP-GT activities on a milligram microsomal protein basis. Histopathologically, no thyroid proliferative lesions were observed in the untreated control group or the DHPN-alone group. However, diffuse follicular cell hypertrophy and decreased colloid in the thyroid were apparent in all rats of the DHPN + KA groups at each time point. In addition, focal follicular cell hyperplasias and adenomas of the thyroid were observed at high incidence in the DHPN + 2% KA group from Week 4 and in the DHPN + 4% KA group from Week 8. Multiplicities of focal follicular cell hyperplasias and adenomas of the thyroid in the DHPN + 2% KA group were significantly greater than those in the DHPN + 4% KA group at Week 8. In the pituitary, an increase in the number of TSH producing cells with expanded cytoplasm was apparent from Weeks 4 to 12 in both DHPN + KA groups. These results strongly suggest that thyroid proliferative lesions were induced by KA administration due to continuous serum TSH stimulation through the negative feedback mechanism of the pituitary-thyroid axis, resulting from depression of serum T3 and T4.
对接受N-双(2-羟丙基)亚硝胺(DHPN:2800mg/kg体重,单次皮下注射)作为启动处理,随后分别给予含0%(第2组)、2%(第3组)或4%(第4组)曲酸(KA)的粉状基础饲料的雄性F344大鼠,在第1、2、4、8和12周时检查甲状腺增殖性病变以及血液中相关激素水平随时间的变化。作为未处理对照组(第1组),大鼠给予基础饲料13周并以相同方式检查。在每个时间点,与单独给予DHPN组相比,DHPN + 2% KA组和DHPN + 4% KA组的血清T3/T4水平显著降低。在第1至12周的治疗期间,两个DHPN + KA组的血清TSH水平在每个时间点均以治疗时间依赖性方式显著升高,且在DHPN + 4% KA组中升高程度更显著。在第2周时,以毫克微粒体蛋白为基础,肝脏T4-UDP-GT活性在组间无统计学显著差异。组织病理学上,在未处理对照组或单独给予DHPN组中未观察到甲状腺增殖性病变。然而,在每个时间点,所有DHPN + KA组大鼠的甲状腺均出现弥漫性滤泡细胞肥大和胶体减少。此外,从第4周起,在DHPN + 2% KA组中高发生率地观察到甲状腺局灶性滤泡细胞增生和腺瘤,从第8周起在DHPN + 4% KA组中观察到。在第8周时,DHPN + 2% KA组甲状腺局灶性滤泡细胞增生和腺瘤的数量显著多于DHPN + 4% KA组。在垂体中,从第4周至12周,两个DHPN + KA组中产生TSH的细胞数量增加且细胞质扩张明显。这些结果强烈表明,由于血清T3和T4降低,通过垂体-甲状腺轴的负反馈机制持续刺激血清TSH,给予KA诱导了甲状腺增殖性病变。